|
Delayed
Australian S.E.
03:59:59 13/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.008000 AUD | 0.00% |
|
0.00% | -66.67% |
| 10-02 | Nexalis Therapeutics Appoints Non-Executive Chairman | MT |
| 10-02 | Nexalis Therapeutics Ltd Announces Board Changes, Effective October 2, 2026 | CI |
| Market Cap | 2.02M 1.35M 1.23M 1.14M 1.03M 1.93M 126M 13.78M 5.47M 68.2M 5.07M 4.96M 216M | P/E 2024 |
-6.17x | P/E 2025 | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.33M 1.55M 1.42M 1.31M 1.19M 2.22M 145M 15.85M 6.29M 78.46M 5.83M 5.71M 249M | EV / Sales 2024 |
18.2x | EV / Sales 2025 | 6.13x |
| Free-Float |
48.36% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -11.11% | ||
| 1 month | -11.11% | ||
| 3 months | -27.27% | ||
| 6 months | -63.64% | ||
| Current year | -66.67% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.03 | |
| 1 year | 0.01 | 0.04 | |
| 3 years | 0.01 | 0.05 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darryl Davies
CEO | Chief Executive Officer | - | 27/09/2022 |
Greg Hammond
DFI | Director of Finance/CFO | - | - |
Rob Jenny
CTO | Chief Tech/Sci/R&D Officer | - | 27/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Darryl Davies
BRD | Director/Board Member | - | 25/06/2026 |
James Barrie
BRD | Director/Board Member | - | 12/05/2026 |
Niv Dagan
CHM | Chairman | - | 02/10/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -72.41% | -79.49% | 1.36M | ||
| +0.19% | -2.90% | +56.40% | +69.15% | 65.45B | ||
| -0.14% | -1.96% | +8.83% | +89.74% | 58.93B | ||
| +0.06% | +0.51% | +26.04% | +87.89% | 55.21B | ||
| -0.97% | -4.83% | +9.83% | +113.88% | 46.1B | ||
| -2.83% | -8.73% | +15.31% | +22.34% | 42.49B | ||
| +3.61% | +3.86% | +22.82% | +46.39% | 35.56B | ||
| -0.24% | -11.77% | +125.89% | +647.44% | 34.57B | ||
| +0.03% | -1.80% | +82.52% | +57.74% | 32.46B | ||
| +20.58% | +19.64% | -28.35% | +482.03% | 26.28B | ||
| Average | +0.20% | -2.64% | +24.69% | +153.71% | 40B | |
| Weighted average by Cap. | +0.06% | -2.69% | +34.88% | +149.70% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 402K 268K 244K 226K 205K 384K 25.05M 2.73M 1.08M 13.54M 1.01M 985K 42.88M | 986K 659K 600K 555K 502K 942K 61.5M 6.71M 2.66M 33.24M 2.47M 2.42M 105M |
| Net income | -1.21M -807K -736K -681K -616K -1.16M -75.4M -8.23M -3.27M -40.75M -3.03M -2.97M -129M | -1.62M -1.08M -985K -911K -824K -1.55M -101M -11.02M -4.37M -54.54M -4.05M -3.97M -173M |
| Net Debt | -161K -107K -97.84K -90.57K -81.92K -154K -10.03M -1.09M -434K -5.42M -403K -394K -17.17M | 304K 203K 185K 171K 155K 291K 18.98M 2.07M 822K 10.26M 762K 746K 32.49M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | A$0.008000 | 0.00% | 1,080,550 |
- Stock Market
- Stocks
- NX1 Stock
Select your edition
All financial news and data tailored to specific country editions
















